Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $709,000 - $1.12 Million
50,000 New
50,000 $1.08 Million
Q1 2022

May 13, 2022

SELL
$59.95 - $92.06 $3.24 Million - $4.98 Million
-54,100 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$81.07 - $121.29 $4.39 Million - $6.56 Million
54,100 New
54,100 $4.39 Million
Q4 2018

Jan 30, 2019

SELL
$35.43 - $56.29 $336,585 - $534,755
-9,500 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$44.22 - $75.47 $420,090 - $716,965
9,500 New
9,500 $541,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $144M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.